- Associated Press•21 days ago
On a per-share basis, the San Diego-based company said it had a loss of 30 cents. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•21 days ago
SAN DIEGO, Aug. 03, 2016-- Conatus Pharmaceuticals Inc., a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results ...
Conatus Pharmaceuticals Inc. (CNAT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||1.85 x 1500|
|Ask||1.95 x 1000|
|Day's Range||1.90 - 2.01|
|52wk Range||1.40 - 7.12|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.52|
|Avg Vol (3m)||107,896|
|Dividend & Yield||N/A (N/A)|